CIDRAP newsletters options
A study yesterday in Cell Reports Medicine shows the B117 variant, first identified in the United Kingdom in December, is 45% more transmissible than the original, wild-type COVID-19 virus, but Pfizer's mRNA vaccine protected elderly populations against infections caused by the variant.
A study of colistin-resistant Enterobacterales (CORE) isolates from patients in southeast Michigan found that increased age and prior antibiotic receipt were associated with increased risk of CORE colonization or infection, researchers reported today in Open Forum Infectious Diseases.
The country's prime minister addressed the nation about the steps officials are taking to get a handle on the massive surge, which is turning into the world's worst.
Agencies didn't perform in the roles identified for the emergency return of US citizens, the GAO says.
Also, NIH will fund a trial to test several existing medications for people to self-administer to treat COVID-19.
An analysis of extracorporeal membrane oxygenation (ECMO) use at 17 intensive care units (ICUs) in the greater Paris area during France's first COVID-19 wave reveal that 90-day survival was strongly linked to a hospital's earlier experience with the procedure. Investigators from France detailed their findings yesterday in The Lancet Respiratory Medicine.
CARB-X announced today that it is awarding Durham, North Carolina, biotech company Baebies Inc. up to $3.9 million to develop a rapid, easy-to-use diagnostic test for sepsis in newborns.
"Big numbers can make us numb. But each one of these deaths is a tragedy for families, communities, and nations."
With thousands of new places to get a vaccine, 9 of 10 Americans live within 5 miles of an immunization site.
Brain abnormalities could explain the confusion and delirium of severe COVID-19.
CARB-X announced today that it is awarding Phico Therapeutics of Cambridge, United Kingdom, up to $5.3 million to develop an intravenous bacteriophage drug to treat ventilator-associated pneumonia caused by Pseudomonas aeruginosa.
A study in an Atlanta school district revealed that the highest secondary COVID-19 attack rates were in indoor, high-contact sports settings (23.8%), staff meetings or lunches (18.2%), and elementary school classrooms (9.5%), and that staff were more susceptible to COVID-19 than students were.
In-hospital COVID death rates are declining, but the virus still poses substantial risk, including a doubled death rate in surgical patients.
Slavitt said vaccination is still the main tool to end the pandemic, and he encouraged all Americans to get the vaccine next week, when eligibility expands.
Artemisinin-based treatment remains highly effective, but resistance mutations and delayed parasite clearance were found.
Should studies show COVID-19 effectiveness, fluvoxamine's supply chain looks resilient, an expert says.
Even countries that managed earlier outbreaks well face surges, and officials say they're tracking the variant fueling India's rise.
Secondary analysis of patients from a postdischarge decolonization trial of methicillin-resistant Staphylococcus aureus (MRSA) carriers found that re-hospitalization for MRSA was associated with extensive exposure to non-MRSA antibiotics and Clostridioides difficile infection (CDI), researchers reported today in Infection Control & Hospital Epidemiology.
UK researchers have uncovered the novel mechanism behind rare abnormal blood clotting seen in some AstraZeneca/Oxford vaccine recipients, according to a study today in the New England Journal of Medicine.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
